Long-term follow-up of neoplastic pancreatic cysts without high-risk stigmata: how often do we change treatment strategy because of malignant transformation?

References

• Canto MI, Hruban RH. Managing pancreatic cysts: less is more? Gastroenterology. 2015;148:688–691.
   PubMed Web of Science ®Google Scholar
• Farrell JJ, Fernández-del Castillo C. Pancreatic cystic neoplasms: management and unanswered questions. Gastroenterology. 2013;144:1303–1315.
   PubMed Web of Science ®Google Scholar
• Del Chiaro M, Verbeke C, Salvia R, et al. European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis. 2013;45:703–711.
   PubMedGoogle Scholar
• Tanaka M, Fernández-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12:183–197.
   PubMed Web of Science ®Google Scholar
• Vege SS, Ziring B, Jain R, et al. American Gastroenterological Association Institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015;148:819–822.
   PubMed Web of Science ®Google Scholar
• Gardner TB, Glass LM, Smith KD, et al. Pancreatic cyst prevalence and the risk of mucin-producing adenocarcinoma in US adults. Am J Gastroenterol. 2013;108:1546–1550.
   PubMed Web of Science ®Google Scholar
• Scheiman JM, Hwang JH, Moayyedi P. American Gastroenterological Association Technical Review on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015;148:824–848.e22.
   PubMed Web of Science ®Google Scholar
• Munigala S, Gelrud A, Agarwal B. Risk of pancreatic cancer in patients with pancreatic cyst. Gastroint Endosc. 2015; Epub ahead of print; 1–6.
   Google Scholar
• Wu BU, Sampath K, Berberian CE, et al. Prediction of malignancy in cystic neoplasms of the pancreas: a Population-Based Cohort Study. Am J Gastroenterol. 2014;109:121–129.
   PubMed Web of Science ®Google Scholar
• Lahav M, Maor Y, Avidan B, et al. Nonsurgical management of asymptomatic incidental pancreatic cysts. Clin Gastroenterol Hepatol. 2007;5:813–817.
   PubMed Web of Science ®Google Scholar
• Tanno S, Nakano Y, Nishikawa T, et al. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results. Gut. 2008;57:339–343.
   PubMed Web of Science ®Google Scholar
• Das A, Wells CD, Nguyen CC. Incidental cystic neoplasms of pancreas: what is the optimal interval of imaging surveillance? Am J Gastroenterol. 2008;103:1657–1662.
   PubMed Web of Science ®Google Scholar
• Sawai Y, Yamao K, Bhatia V, et al. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms. Endoscopy. 2010;42:1077–1084.
   PubMed Web of Science ®Google Scholar
• Malleo G, Marchegiani G, Borin A, et al. Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm. Ann Surg. 2015;261:984–990.
   PubMed Web of Science ®Google Scholar
• Marchegiani G, Malleo G, D’Haese JG, et al. Association between pancreatic intraductal papillary mucinous neoplasms and extrapancreatic malignancies. Clin Gastroenterol Hepatol. 2015;13:1162–1169.
   PubMed Web of Science ®Google Scholar
• Chung JW, Chung MJ, Park JY, et al. Clinicopathologic features and outcomes of pancreatic cysts during a 12-year period. Pancreas. 2013;42:230–238.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17–32.
   PubMed Web of Science ®Google Scholar
• Bosman F, Carneiro F, Hruban R, Theise N. WHO classification of tumors of digestive system. Geneva, Switzerland: WHO Press; 2010. p. 304e13.
   Google Scholar
• Reddy RP, Smyrk TC, Zapiach M, et al. Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer. Clin Gastroenterol Hepatol. 2004;2:1026–1031.
   PubMed Web of Science ®Google Scholar
• Crippa S, Salvia R, Warshaw AL, et al. Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg. 2008;247:571–579.
   PubMed Web of Science ®Google Scholar
• Khannoussi W, Vullierme MP, Rebours V, et al. The long term risk of malignancy in patients with branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreatology. 2012;12:198–202.
   PubMed Web of Science ®Google Scholar
• Östör A. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993;12:186–192.
   PubMed Web of Science ®Google Scholar
• Wani S, Puli S, Shaheen N, et al. Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systematic review. Am J Gastroenterol. 2009;104:502–513.
   PubMed Web of Science ®Google Scholar
• Winter JM, Cameron JL, Campbell KA, et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg. 2006;10:1199–1210.
   PubMed Web of Science ®Google Scholar
• Newhook TE, LaPar DJ, Lindberg JM, et al. Morbidity and mortality of pancreaticoduodenectomy for benign and premalignant pancreatic neoplasms. J Gastrointest Surg. 2015;19:1072–1077.
   PubMed Web of Science ®Google Scholar
• Ngamruengphong S, Bartel MJ, Raimondo M. Cyst carcinoembryonic antigen in differentiating pancreatic cysts: a meta-analysis. Dig Liver Dis. 2013;45:920–926.
   PubMedGoogle Scholar
• Amato E, Molin MD, Mafficini A, et al. Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. J Pathol. 2014;233:217–227.
   PubMed Web of Science ®Google Scholar
• Wu J, Matthaei H, Maitra A, et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med. 2011;3:1–19.
   Web of Science ®Google Scholar
• Dal Molin M, Matthaei H, Wu J, et al. Clinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Surg Oncol. 2013;20:3802–3808.
   PubMed Web of Science ®Google Scholar
• Wada K. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas. J Hepatobiliary Pancreat Surg. 2002;9:76–85.
   PubMedGoogle Scholar
• Paini M, Crippa S, Partelli S, et al. Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas. World J Gastroenterol: WJG. 2014;20:10008–10023.
   PubMed Web of Science ®Google Scholar
• Nissim S, Idos GE, Wu B. Genetic markers of malignant transformation in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis. Pancreas. 2012;41:1195–1205.
   PubMed Web of Science ®Google Scholar
• Al-haddad M, Kowalski T, Siddiqui A, et al. Integrated molecular pathology accurately determines the malignant potential of pancreatic cysts. Endoscopy. 2015;47:136–142.
   PubMed Web of Science ®Google Scholar